Korean J Prev Med.
1999 Sep;32(3):333-342.
The Prevalence of Cancer in Kangwha County
- Affiliations
-
- 1Department of Preventive Medicine and Public Health, College of Medicine, Yonsei
University, Korea.
- 2Department of Preventive Medicine, Catholic University of Korea, Korea.
- 3Department of Preventive Medicine, College of Medicine, Pochon Cha University, Korea.
- 4Graduate School of Health Science and Management, Yonsei University, Korea.
Abstract
OBJECTIVES
Most descriptive studies of cancer have focused either on cancer incidence or
mortality. Cancer prevalence has rarely been estimated. Cancer prevalence data can be
used as a measure of the economic and social burden of cancer and are also useful for
health care planning. This study attempts to estimate cancer prevalence in Kangwha
county.
METHODS
This investigation is based on data of Kangwha cancer registry. The data
include all cases of cancer diagnosed from 1983 through 1992. We define "prevalent
cases" as cancer patients who is alive as of January 1, 1993. For each five-year age
group, the number of "known prevalent cases" is added to the number of "estimated
prevalent cases". Prevalence is calculated by dividing these sums by the populations of
Kangwha County on December 31, 1992(derived from Kangwha Statistics Annual).
RESULTS
Crude prevalence of cancer among males and females are 536.7 and 601.1 per
100,000 respectively. Gastric cancer is the most common malignant neoplasm(213.2 per
100,000, crude prevalence) among males. It is followed by lung cancer(45.1 per 100,000),
liver cancer(32.8 per 100,000), rectal cancer(25.4 per 100,000) and colon cancer(25.4 per
100,000). Cervical cancer is the most common cancer(201.9 per 100,000, crude prevalence)
and is followed by gastric cancer(91.5 per 100,000), thyroid cancer(64.8 per 100,000),
breast cancer(57.2 per 100,000) and rectal cancer(32.7 per 100,000) among females.
CONCLUSIONS
We tried to estimate cancer prevalence based on the Kangwha cancer
registry for the first time in Korea. The estimation of cancer prevalence based on a
population-based cancer registry will be more correct and useful as the data accumulate.
We will make another estimation in the near future.